Standout Papers

Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer 2023 2026 202476
  1. Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer (2023)
    Charles M. Rudin, Martin Reck et al. Journal of Hematology & Oncology

Immediate Impact

6 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Biological Utility of Fluorinated Compounds: from Materials Design to Molecular Imaging, Therapeutics and Environmental Remediation
2021 Standout
3 intermediate papers

Works of Gwyn Bebb being referenced

Characterization of a murine model of metastatic human non-small cell lung cancer and effect of CXCR4 inhibition on the growth of metastases
2015
Antitumor Efficacy of Oblimersen Bcl-2 Antisense Oligonucleotide Alone and in Combination with Vinorelbine in Xenograft Models of Human Non–Small Cell Lung Cancer
2004

Author Peers

Author Last Decade Papers Cites
Gwyn Bebb 625 299 352 47 1.1k
Vincenzo Sforza 662 351 369 58 1.1k
Guidalberto Fabris 571 319 225 46 1.2k
Sharon B. Sams 497 203 377 39 1000
Véronique D’Hondt 763 329 287 81 1.3k
J J Costanzi 635 281 293 36 1.2k
J F Holland 651 239 419 47 1.3k
E.J. Shpall 558 216 247 47 1.4k
Chiara Pierantoni 793 362 338 40 1.2k
Renato V. LaRocca 413 335 295 47 1.4k
Conleth G. Murphy 978 417 308 54 1.4k

All Works

Loading papers...

Rankless by CCL
2026